Protein / target
Tyrosine-protein phosphatase non-receptor type 6
Protein at a glance
Biological role
Transmembrane receptor protein tyrosine phosphatase
Strongest disease association
Lymphoma, Large B-Cell, Diffuse
Research activity
Emerging research
Derived from structured UniProt, Open Targets and literature data on this page.
Protein profile
Canonical identity and biological annotation from UniProt.
Function overview
Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling pathways and fundamental physiological processes such as hematopoiesis.
View complete UniProt function annotationHide complete annotation
Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling pathways and fundamental physiological processes such as hematopoiesis (PubMed:14739280, PubMed:29925997). Dephosphorylates and negatively regulate several receptor tyrosine kinases (RTKs) such as EGFR, PDGFR and FGFR, thereby modulating their signaling activities (PubMed:21258366, PubMed:9733788). When recruited to immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing receptors such as immunoglobulin-like transcript 2/LILRB1, programmed cell death protein 1/PDCD1, CD3D, CD22, CLEC12A and other receptors involved in immune regulation, initiates their dephosphorylation and subsequently inhibits downstream signaling events (PubMed:11907092, PubMed:14739280, PubMed:37932456, PubMed:38166031). Modulates the signaling of several cytokine receptors including IL-4 receptor (PubMed:9065461). Additionally, targets multiple cytoplasmic signaling molecules including STING1, LCK or STAT1 among others involved in diverse cellular processes including modulation of T-cell activation or cGAS-STING signaling (PubMed:34811497, PubMed:38532423). Within the nucleus, negatively regulates the activity of some transcription factors such as NFAT5 via direct dephosphorylation. Also acts as a key transcriptional regulator of hepatic gluconeogenesis by controlling recruitment of RNA polymerase II to the PCK1 promoter together with STAT5A (PubMed:37595871)
Subcellular location
Domains and Gene Ontology detail (53)Hide
Domains & features
Gene Ontology
- Calpha-beta T cell receptor complex
- Ccell-cell junction
- Ccytoplasm
- Ccytosol
- Cextracellular exosome
- Cextracellular region
- Cmembrane
- Cnucleolus
- Cnucleoplasm
- Cnucleus
- Cplasma membrane
- Cprotein-containing complex
Biological roles
What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.
View supporting evidenceHide supporting evidence
Cell proliferation & survival
- ·negative regulation of cell population proliferation
- ·positive regulation of cell population proliferation
Cell-cycle regulation
- ·mitotic cell cycle
- ·regulation of G1/S transition of mitotic cell cycle
Receptor tyrosine kinase signalling
- ·Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling p…
Immune signalling
- ·Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling p…
- ·alpha-beta T cell receptor complex
- ·cytokine-mediated signaling pathway
- ·negative regulation of B cell receptor signaling pathway
Apoptosis & cell death
- ·Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling p…
- ·regulation of apoptotic process
Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.
Translational evidence
Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.
Strongest disease associations · via encoding gene PTPN6
Gene-level evidence surfaced through the gene PTPN6that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.
View evidence synthesis (5)Hide
The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.
Show all associationsHide all associations
Tractability
Small molecules — Emerging
Antibodies — Emerging
Protein degraders — Emerging
View underlying tractability evidence (7)Hide
Raw Open Targets tractability assessment buckets, by modality.
Safety-related annotations
Terms indexed against this target in Open Targets' safety data, with their datasource. These are annotations, not causal claims: the direction of effect (whether activation or inhibition is implicated), species and evidence strength are not captured here, so an entry does not mean that modulating this target is known to cause that condition.
Research activity
Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.
Most cited
Recent
Europe PMC papers linked directly to this protein.